Company / Net Debt per Share
IRONWOOD PHARMACEUTICALS INC Net Debt per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.38
FY2022
5-year range
-$1.38 / -$1.03
FY2020-FY2022
Trend
-33.7%
vs FY2021
Sector context
#63 of 82
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's net debt per share of $-1.38 is lower than 77% of companies in the Health Care sector (FY2022). Improved from $1.61 to $-1.38 over the past 2 years.
Based on SEC 10-K filings.
-1.38 in FY2022.
Improved from $1.61 to $-1.38 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 82This company -$1.38 Sector average $1.13
▼
-222.2% below sector average
Key checks
Key Insights
- In FY2022, net debt per share decreased 33.7% year-over-year.
- Ranks #63 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$1.38 | -33.7% |
| FY2021 | -$1.03 | -164.3% |
| FY2020 | $1.61 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026